Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.

To predict acute Radiation Therapy Oncology Group (RTOG)/European Organization for Research and Treatment of Cancer (EORTC) and Subjective Objective Signs Management and Analysis/Late Effect of Normal Tissue (SOMA/LENT) toxicities of the lower gastrointestinal (LGI) syndrome in patients with prostate cancer undergoing three-dimensional conformal radiotherapy using a tool (nomogram) that takes into account clinical and dosimetric variables that proved to be significant in the Italian Association for Radiation Oncology (AIRO) Group on Prostate Cancer (AIROPROS) 0102 trial.
Acute rectal toxicity was scored in 1,132 patients by using both the RTOG/EORTC scoring system and a 10-item self-assessed questionnaire. Correlation between clinical variables/dose-volume histogram constraints and rectal toxicity was investigated by means of multivariate logistic analyses. Multivariate logistic analyses results were used to create nomograms predicting the symptoms of acute LGI syndrome.
Mean rectal dose was a strong predictor of Grade 2-3 RTOG/EORTC acute LGI toxicity (p = 0.0004; odds ratio (OR) = 1.035), together with hemorrhoids (p = 0.02; OR = 1.51), use of anticoagulants/antiaggregants (p = 0.02; OR = 0.63), and androgen deprivation (AD) (p = 0.04; OR = 0.65). Diabetes (p = 0.34; OR = 1.28) and pelvic node irradiation (p = 0.11; OR = 1.56) were significant variables to adjust toxicity prediction. Bleeding was related to hemorrhoids (p = 0.02; OR = 173), AD (p = 0.17; OR = 0.67), and mean rectal dose (p = 0.009; OR = 1.024). Stool frequency was related to seminal vesicle irradiation (p = 0.07; OR = 6.46), AD administered for more than 3 months (p = 0.002; OR = 0.32), and the percent volume of rectum receiving more than 60 Gy (V60Gy) V60 (p = 0.02; OR = 1.02). Severe fecal incontinence depended on seminal vesicle irradiation (p = 0.14; OR = 4.5) and V70 (p = 0.033; OR = 1.029).
To the best of our knowledge, this work presents the first set of nomograms available in the literature specific to symptoms of LGI syndrome and provides clinicians with a tailored probability of the specific outcome. Validation of the tool is in progress.
AuthorsRiccardo Valdagni, Tiziana Rancati, Claudio Fiorino, Gianni Fellin, Alessandro Magli, Michela Baccolini, Carla Bianchi, Emanuela Cagna, Carlo Greco, Flora A Mauro, Angelo F Monti, Fernando Munoz, Michele Stasi, Paola Franzone, Vittorio Vavassori
JournalInternational journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 71 Issue 4 Pg. 1065-73 (Jul 15 2008) ISSN: 0360-3016 [Print] United States
PMID18234449 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
  • Algorithms
  • Comorbidity
  • Dose-Response Relationship, Radiation
  • Gastrointestinal Diseases (epidemiology)
  • Humans
  • Incidence
  • Italy (epidemiology)
  • Male
  • Models, Biological
  • Outcome Assessment (Health Care) (methods)
  • Prognosis
  • Prostatic Neoplasms (epidemiology, radiotherapy)
  • Radiation Injuries (epidemiology)
  • Radiotherapy Dosage
  • Radiotherapy, Conformal (statistics & numerical data)
  • Reproducibility of Results
  • Risk Assessment (methods)
  • Risk Factors
  • Sensitivity and Specificity
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: